Literature DB >> 32054658

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor.

Naoya Uchida1, Alexis Leonard1, David Stroncek2, Sandhya R Panch2, Kamille West2, Eoghan Molloy2, Thomas E Hughes3, Sara Hauffe4, Tiffani Taylor1, Courtney Fitzhugh1, Jane S Hankins5, Megan Wilson5, Akshay Sharma6, Shengdar Q Tsai5, Mitch J Weiss5, Matthew Hsieh7, John F Tisdale1.   

Abstract

Keywords:  Gene Therapy and Transfer; Hematopoietic Stem Cell; Hemoglobinopathies; Stem Cell Transplantation

Year:  2020        PMID： 32054658      PMCID： PMC7556661          DOI： 10.3324/haematol.2019.236182

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Fatal sickle cell crisis after granulocyte colony-stimulating factor administration.

Authors:  B K Adler; D E Salzman; M H Carabasi; W P Vaughan; V V Reddy; J T Prchal
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

2.  SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.

Authors:  Jianfeng Wang; Takafumi Kimura; Rumiko Asada; Sachio Harada; Shouhei Yokota; Yoshio Kawamoto; Yoshihiro Fujimura; Takashi Tsuji; Susumu Ikehara; Yoshiaki Sonoda
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

3.  AC133, a novel marker for human hematopoietic stem and progenitor cells.

Authors:  A H Yin; S Miraglia; E D Zanjani; G Almeida-Porada; M Ogawa; A G Leary; J Olweus; J Kearney; D W Buck
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

4.  Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.

Authors:  Alexis Leonard; Aylin Bonifacino; Venina M Dominical; Min Luo; Juan J Haro-Mora; Selami Demirci; Naoya Uchida; Francis J Pierciey; John F Tisdale
Journal:  Br J Haematol       Date:  2019-04-10       Impact factor: 6.998

5.  Gene Therapy in a Patient with Sickle Cell Disease.

Authors:  Jean-Antoine Ribeil; Salima Hacein-Bey-Abina; Emmanuel Payen; Alessandra Magnani; Michaela Semeraro; Elisa Magrin; Laure Caccavelli; Benedicte Neven; Philippe Bourget; Wassim El Nemer; Pablo Bartolucci; Leslie Weber; Hervé Puy; Jean-François Meritet; David Grevent; Yves Beuzard; Stany Chrétien; Thibaud Lefebvre; Robert W Ross; Olivier Negre; Gabor Veres; Laura Sandler; Sandeep Soni; Mariane de Montalembert; Stéphane Blanche; Philippe Leboulch; Marina Cavazzana
Journal:  N Engl J Med       Date:  2017-03-02       Impact factor: 91.245

6.  Collection of blood stem cells from patients with sickle cell anemia.

Authors:  Robert E Richard; Noppadol Siritanaratkul; Erica Jonlin; Eva Skarpidi; Shelly Heimfeld; C Anthony Blau
Journal:  Blood Cells Mol Dis       Date:  2005-08-26       Impact factor: 3.039

7.  Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?

Authors:  Courtney D Fitzhugh; Matthew M Hsieh; Charles D Bolan; Carla Saenz; John F Tisdale
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

8.  The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.

Authors:  Georgine E de Greef; Eric Braakman; Bronno van der Holt; Jeroen J W M Janssen; Eefke Petersen; Vladimir Vucinic; Nicole Thuss; Meriam Grootes; Jan J Cornelissen
Journal:  Transfusion       Date:  2018-12-11       Impact factor: 3.157

9.  Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion.

Authors:  Chantal Lagresle-Peyrou; François Lefrère; Elisa Magrin; Jean-Antoine Ribeil; Oriana Romano; Leslie Weber; Alessandra Magnani; Hanem Sadek; Clémence Plantier; Aurélie Gabrion; Brigitte Ternaux; Tristan Félix; Chloé Couzin; Aurélie Stanislas; Jean-Marc Tréluyer; Lionel Lamhaut; Laure Joseph; Marianne Delville; Annarita Miccio; Isabelle André-Schmutz; Marina Cavazzana
Journal:  Haematologica       Date:  2018-02-22       Impact factor: 9.941

10.  Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.

Authors:  Farid Boulad; Tsiporah Shore; Koen van Besien; Caterina Minniti; Mihaela Barbu-Stevanovic; Sylvie Wiener Fedus; Fabiana Perna; June Greenberg; Danielle Guarneri; Vijay Nandi; Audrey Mauguen; Karina Yazdanbakhsh; Michel Sadelain; Patricia A Shi
Journal:  Haematologica       Date:  2018-02-01       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.